The device was not returned for evaluation as the stent remains in the patient.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of angina is listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
Patient id: (b)(6).It was reported that on (b)(6) 2020 the 2.25x12 mm xience sierra stent was implanted in the right posterior descending coronary artery.On (b)(6) 2020 the patient had throat tightness, left arm pain, dyspnea, and occasional chest pressure.The symptoms worsened, thus the patient went to the emergency room.The patient was admitted to the hospital on (b)(6) 2020.An echocardiogram was the only diagnostic performed and there were no changes on the (b)(6) 2020 echocardiogram compared to the (b)(6) 2020 echocardiogram.The condition resolved and the patient was discharged on (b)(6) 2020.No additional information was provided.
|